128 related articles for article (PubMed ID: 9251015)
1. Chemical inhibitors of cyclin-dependent kinases.
Meijer L; Kim SH
Methods Enzymol; 1997; 283():113-28. PubMed ID: 9251015
[No Abstract] [Full Text] [Related]
2. Purification and reconstitution of cyclin-dependent kinase 2 in four states of activity.
Russo AA
Methods Enzymol; 1997; 283():3-12. PubMed ID: 9251007
[No Abstract] [Full Text] [Related]
3. Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2.
Lawrie AM; Noble ME; Tunnah P; Brown NR; Johnson LN; Endicott JA
Nat Struct Biol; 1997 Oct; 4(10):796-801. PubMed ID: 9334743
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
[TBL] [Abstract][Full Text] [Related]
5. Cdk2/cdc2 expression in colon carcinogenesis and effects of cdk2/cdc2 inhibitor in colon cancer cells.
Yamamoto H; Monden T; Miyoshi H; Izawa H; Ikeda K; Tsujie M; Ohnishi T; Sekimoto M; Tomita N; Monden M
Int J Oncol; 1998 Aug; 13(2):233-9. PubMed ID: 9664116
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase.
De Azevedo WF; Mueller-Dieckmann HJ; Schulze-Gahmen U; Worland PJ; Sausville E; Kim SH
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2735-40. PubMed ID: 8610110
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of C2 alkynylated purines, a new family of potent inhibitors of cyclin-dependent kinases.
Legraverend M; Ludwig O; Bisagni E; Leclerc S; Meijer L
Bioorg Med Chem Lett; 1998 Apr; 8(7):793-8. PubMed ID: 9871543
[TBL] [Abstract][Full Text] [Related]
8. Purification of recombinant cyclin B1/cdc2 kinase from Xenopus egg extracts.
Wilhelm H; Andersen SS; Karsenti E
Methods Enzymol; 1997; 283():12-28. PubMed ID: 9251008
[No Abstract] [Full Text] [Related]
9. Structure-based design of potent CDK1 inhibitors derived from olomoucine.
Furet P; Zimmermann J; Capraro HG; Meyer T; Imbach P
J Comput Aided Mol Des; 2000 Jul; 14(5):403-9. PubMed ID: 10896313
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinases and cyclin-dependent kinase inhibitors. Detection methods and activity measurements.
Brooks G
Methods Mol Biol; 2001; 124():161-70. PubMed ID: 11100474
[No Abstract] [Full Text] [Related]
11. Differences in substrate specificity between Cdk2-cyclin A and Cdk2-cyclin E in vitro.
Higashi H; Suzuki-Takahashi I; Taya Y; Segawa K; Nishimura S; Kitagawa M
Biochem Biophys Res Commun; 1995 Nov; 216(2):520-5. PubMed ID: 7488142
[TBL] [Abstract][Full Text] [Related]
12. Butyrolactone: more than a kinase inhibitor?
Bloom J; Pagano M
Cell Cycle; 2002; 1(2):117-8. PubMed ID: 12429918
[No Abstract] [Full Text] [Related]
13. Under arrest at atomic resolution.
Morgan DO
Nature; 1996 Jul; 382(6589):295-6. PubMed ID: 8684452
[No Abstract] [Full Text] [Related]
14. Identification of cylin-dependent kinase 1 inhibitors of a new chemical type by structure-based design and database searching.
Furet P; Meyer T; Mittl P; Fretz H
J Comput Aided Mol Des; 2001 May; 15(5):489-95. PubMed ID: 11394741
[TBL] [Abstract][Full Text] [Related]
15. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.
Hoessel R; Leclerc S; Endicott JA; Nobel ME; Lawrie A; Tunnah P; Leost M; Damiens E; Marie D; Marko D; Niederberger E; Tang W; Eisenbrand G; Meijer L
Nat Cell Biol; 1999 May; 1(1):60-7. PubMed ID: 10559866
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design and synthesis of 2-benzylidene-benzofuran-3-ones as flavopiridol mimics.
Schoepfer J; Fretz H; Chaudhuri B; Muller L; Seeber E; Meijer L; Lozach O; Vangrevelinghe E; Furet P
J Med Chem; 2002 Apr; 45(9):1741-7. PubMed ID: 11960485
[TBL] [Abstract][Full Text] [Related]
17. 1H-Pyrazolo[3,4-b]pyridine inhibitors of cyclin-dependent kinases.
Misra RN; Rawlins DB; Xiao HY; Shan W; Bursuker I; Kellar KA; Mulheron JG; Sack JS; Tokarski JS; Kimball SD; Webster KR
Bioorg Med Chem Lett; 2003 Mar; 13(6):1133-6. PubMed ID: 12643928
[TBL] [Abstract][Full Text] [Related]
18. Generation of phosphorylated cyclin-dependent kinase 2 and functional characterization of threonine-160-specific phosphatase KAP.
Poon RY
Methods Enzymol; 1997; 283():283-92. PubMed ID: 9251027
[No Abstract] [Full Text] [Related]
19. Stoichiometry of cyclin A-cyclin-dependent kinase 2 inhibition by p21Cip1/Waf1.
Adkins JN; Lumb KJ
Biochemistry; 2000 Nov; 39(45):13925-30. PubMed ID: 11076534
[TBL] [Abstract][Full Text] [Related]
20. Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1).
Hengst L; Göpfert U; Lashuel HA; Reed SI
Genes Dev; 1998 Dec; 12(24):3882-8. PubMed ID: 9869641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
